Role of Macrophage in the pathogenesis of diabetic nephropathy revealed by ICAM-1 deficient mice.
ICAM-1 缺陷小鼠揭示巨噬细胞在糖尿病肾病发病机制中的作用。
基本信息
- 批准号:13671116
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Diabetic nephropathy is a leading cause of end-stage renal failure. Several mechanisms, including activation of protein kinase C, advanced glycation end products, and overexpression of transforming growth factor (TGF)-beta, are believed to be involved in the pathogenesis of diabetic nephropathy. However, the significance of inflammatory processes in the pathogenesis of diabetic microvascular complications is poorly understood. Accumulation of macrophages and overexpression of leukocyte adhesion molecules and chemokines are prominent in diabetic human kidney tissues. We previously demonstrated that intercellular adhesion molecule (ICAM)-1 mediates macrophage infiltration into the diabetic kidney. In the present study, to investigate the role of macrophage in diabetic nephropathy, we induced diabetes in ICAM-1-deficient (ICAM-1(-/-)) mice and ICAM-1(+/+) mice with streptozotocin and examined the renal pathology over a period of 6 months. The infiltration of macrophages was markedly suppressed in diabetic ICAM-1(-/-) mice compared with that of ICAM-1(+/+) mice. Urinary albumin excretion, glomerular hypertrophy, and mesangial matrix expansion were significantly lower in diabetic ICAM-1(-/-) mice than in diabetic ICAM-1(+/+) mice. Moreover, expressions of TGF-beta and type IV collagen in glomeruli were also suppressed in diabetic ICAM-1(-/-) mice. Moreover, we investigated the gene expression profiles in the kidneys. of these mice using DNA microarray system. Proinflammatory genes are up-regulated in the kidneys of diabetic ICAM-1(+/+) mice, while the expression levels of these genes were decresased in diabetic ICAM-1(-/-) mice as compared to ICAM-1(+/+) mice. These results suggest that ICAM-1 is critically involved in the pathogenesis of diabetic nephropathy.
糖尿病肾病是终末期肾功能衰竭的主要原因。多种机制,包括蛋白激酶C的激活、晚期糖基化终产物和转化生长因子(TGF)- β的过度表达,被认为参与了糖尿病肾病的发病机制。然而,炎症过程在糖尿病微血管并发症发病机制中的意义尚不清楚。巨噬细胞的积累和白细胞粘附分子和趋化因子的过度表达在糖尿病人肾脏组织中是突出的。我们之前证明了细胞间粘附分子(ICAM)-1介导巨噬细胞浸润到糖尿病肾脏。在本研究中,为了研究巨噬细胞在糖尿病肾病中的作用,我们用链脲佐菌素诱导ICAM-1缺陷(ICAM-1(-/-))小鼠和ICAM-1(+/+)小鼠患糖尿病,并在6个月的时间内观察肾脏病理。与ICAM-1(+/+)小鼠相比,糖尿病ICAM-1(-/-)小鼠的巨噬细胞浸润明显受到抑制。糖尿病ICAM-1(-/-)小鼠的尿白蛋白排泄、肾小球肥大和系膜基质扩张明显低于糖尿病ICAM-1(+/+)小鼠。此外,糖尿病ICAM-1(-/-)小鼠肾小球中tgf - β和IV型胶原的表达也受到抑制。此外,我们还研究了肾脏中的基因表达谱。利用DNA微阵列系统对这些小鼠进行检测。促炎基因在糖尿病ICAM-1(+/+)小鼠肾脏中表达上调,而与ICAM-1(+/+)小鼠相比,这些基因在糖尿病ICAM-1(-/-)小鼠肾脏中的表达水平降低。这些结果表明,ICAM-1在糖尿病肾病的发病机制中起关键作用。
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yamashita T, Shikata K, Matsuda M, Okada S, Ogawa D, Sugimoto H, Wada J, Makino H.: "Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats."Dia
Yamashita T、Shikata K、Matsuda M、Okada S、Okawa D、Sugimoto H、Wada J、Makino H.:“贝前列素钠、前列环素类似物,通过调节糖尿病大鼠的 ecNOS 表达来减轻肾小球过度滤过和肾小球巨噬细胞浸润。”Dia
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hiragushi K, Wada J, Eguchi J, Matsuoka T, Yasuhara A, Hashimoto I, Yamashita T, Hida K, Nakamura Y, Shikata K, Minamino N, Kangawa K, Makino H.: "The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic ra
Hiragushi K、Wada J、Eguchi J、Matsuoka T、Yasuhara A、Hashimoto I、Yamashita T、Hida K、Nakamura Y、Shikata K、Minamino N、Kangawa K、Makino H.:“肾上腺髓质素和受体在肾小球超滤过中的作用
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ymashita T, Shikata K et al.: "Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats."Diabetes Res Clin Pract. 57. 149-161 (2002)
Ymashita T、Shikata K 等人:“贝前列素钠,前列环素类似物,通过调节糖尿病大鼠的 ecNOS 表达来减轻肾小球过度滤过和肾小球巨噬细胞浸润。”糖尿病研究临床实践。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ogawa D, Shikata K et al.: "Cerebroside sulfotransferase deficiency ameliorates L-selectin-dependent monocyte infiltration in the kidney after ureteral obstruction."J Biol Chem. 16. 2085-2090 (2004)
Okawa D、Shikata K 等人:“脑苷脂磺基转移酶缺乏可改善输尿管梗阻后肾脏中 L-选择素依赖性单核细胞浸润。”J Biol Chem。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Okada S, Shikata K et al.: "Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes,"Diabetes. 52. 2586-2593 (2003)
Okada S、Shikata K 等人:“细胞间粘附分子 1 缺陷的小鼠在诱导糖尿病后能够抵抗肾损伤”,糖尿病。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHIKATA Kenichi其他文献
SHIKATA Kenichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHIKATA Kenichi', 18)}}的其他基金
Development of the novel therapeutic strategy for diabetic nephropathy through anti-inflammatory effects.
通过抗炎作用开发糖尿病肾病的新治疗策略。
- 批准号:
21591031 - 财政年份:2009
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Exploratory research to development of novel therapeutic strategy for diabetic nephropathy
糖尿病肾病治疗新策略的探索性研究
- 批准号:
19590952 - 财政年份:2007
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel therapeutic targets for diabetic nephropathy.
糖尿病肾病的新治疗靶点。
- 批准号:
17590828 - 财政年份:2005
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of Macrophage in the pathogenesis of diabetic nephropathy and novel therapeutic target.
巨噬细胞在糖尿病肾病发病机制中的作用及新的治疗靶点。
- 批准号:
15590850 - 财政年份:2003
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Application of anti-adhesion molecule therapy for glomerulonephritis -Effects of sulfated oligosaccharides as selectin-blocking agents-
抗粘连分子疗法在肾小球肾炎中的应用-硫酸化寡糖作为选择素阻断剂的作用-
- 批准号:
11671036 - 财政年份:1999
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanism of inflammatory cell infiltration in the kidney tissue of glomerulonephritis and diabetic nephropathy. -Elucidation of the role of cell adhesion molecules and development of therapeutic drugs.-
肾小球肾炎和糖尿病肾病肾组织炎症细胞浸润机制。
- 批准号:
06671141 - 财政年份:1994
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
Macrophage和Treg在移植免疫调节中的相互作用及其机制研究
- 批准号:81102247
- 批准年份:2011
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Targeting kidney resident macrophage niche filling to slow cystic kidney disease
靶向肾脏常驻巨噬细胞生态位填充以减缓囊性肾病
- 批准号:
10518723 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Targeting kidney resident macrophage niche filling to slow cystic kidney disease
靶向肾脏常驻巨噬细胞生态位填充以减缓囊性肾病
- 批准号:
10705287 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Smart nanomedicine-mediated functional switching of macrophage and treatment of chronic kidney disease (CKD)
智能纳米医学介导的巨噬细胞功能转换和慢性肾病(CKD)的治疗
- 批准号:
22H03968 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Complement regulates macrophage and platelet function in kidney transplants
补体调节肾移植中的巨噬细胞和血小板功能
- 批准号:
10490858 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Complement regulates macrophage and platelet function in kidney transplants
补体调节肾移植中的巨噬细胞和血小板功能
- 批准号:
10337999 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Complement regulates macrophage and platelet function in kidney transplants
补体调节肾移植中的巨噬细胞和血小板功能
- 批准号:
10681424 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
the mechanism of albumin reabsorption moduleted by macrophage driving proxymal tubules damage in diabetic kidney
巨噬细胞驱动糖尿病肾代理肾小管损伤的白蛋白重吸收机制
- 批准号:
18K15981 - 财政年份:2018
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Treatment strategy for kidney disease based on TLR4-macrophage control by alfa1-acid glycoprotein
基于α1-酸性糖蛋白控制TLR4-巨噬细胞的肾脏疾病治疗策略
- 批准号:
16K15320 - 财政年份:2016
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Renal pericytes express phagocyte/macrophage-like function after kidney injury
肾损伤后肾周细胞表达吞噬细胞/巨噬细胞样功能
- 批准号:
15K19456 - 财政年份:2015
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Ferritin mediates epithelial cell-macrophage cross talk in acute kidney injury
铁蛋白介导急性肾损伤中上皮细胞-巨噬细胞的相互作用
- 批准号:
8805166 - 财政年份:2014
- 资助金额:
$ 2.24万 - 项目类别: